Joint Restoration With Regenerative Medicine Benefits

Abstract

In this educational post, I will delve into the complex and fascinating world of regenerative medicine, specifically focusing on its application for osteoarthritis (OA). We will explore critical questions I often discuss with colleagues and patients, such as patient candidacy for treatments like Platelet-Rich Plasma (PRP), the nuanced differences among PRP preparations, and the integration of these advanced therapies with foundational care, such as chiropractic adjustments. Drawing on the latest evidence-based research and my own clinical observations, this journey will unpack the physiological mechanisms behind these treatments. We will discuss how to manage patient expectations, navigate post-injection protocols, and optimize outcomes by understanding concepts such as cellular dosage, inflammatory responses, and the synergistic potential of combining biologic agents. The goal is to provide a comprehensive, easy-to-understand guide for both patients seeking answers and practitioners looking to deepen their knowledge, all grounded in the principles of integrative and functional medicine.

As a practitioner with a deep commitment to integrative and functional medicine, I am constantly engaged in conversations about the cutting edge of healing. My colleagues and I recently had a dynamic exchange following a presentation on the latest findings in regenerative therapies. The questions raised were insightful and touched upon the very core of what we do in clinical practice: How do we select the right patients? How do we tailor treatments for maximum efficacy? And how do we manage expectations in a field brimming with both promise and complexity?

This post reflects that dialogue, reworded from my first-person perspective to take you on a journey through these critical topics. My goal is to illuminate the science, share clinical pearls, and showcase how we integrate these modern approaches into a holistic treatment paradigm.

Determining Patient Candidacy for Regenerative Therapies: Beyond the X-Ray

A recurring and crucial question in regenerative medicine is: “Who is the ideal candidate for a procedure like Platelet-Rich Plasma (PRP) for osteoarthritis?” It’s tempting to look for simple cutoffs based on Body Mass Index (BMI), age, or the severity of arthritis seen on an X-ray. However, my experience, supported by emerging research, shows that the decision is far more nuanced.

I don’t use rigid cutoffs for BMI or age. While there can be a bias against higher BMI, the mechanism of PRP involves modulating the local inflammatory environment, which can be beneficial regardless of a patient’s weight. Age is also not a definitive barrier; we have successfully treated patients in their 90s who have responded wonderfully.

The Symptom Profile: A Better Predictor of Success

Instead of relying solely on imaging or demographics, I find that the patient’s symptom profile is the most powerful predictor of their response to treatment. This is a key clinical observation I’ve made over the years.

• Good Candidates: Patients who describe their pain as a broad, achy, and inflammatory sensation often respond exceptionally well. This type of pain suggests that a significant component of their discomfort is driven by a pro-inflammatory biochemical environment within the joint. PRP is uniquely suited to address this by introducing a high concentration of growth factors and signaling molecules that can modulate this inflammation and promote a healing cascade.
• More Challenging Candidates: Conversely, patients who report sharp, stabbing, or pressure-type pain, especially with specific movements, may have a more complex mechanical issue at play. This often correlates with more severe structural damage, such as significant cartilage loss leading to “bone-on-bone” contact or the presence of bone marrow lesions or meniscal pathology. These individuals can still benefit from PRP, but our treatment algorithm must be more comprehensive. We need to address the other pain generators, and it’s essential to have a frank conversation about expectations.

Managing Expectations: The Art of the Possible

When a patient comes to me after being told they need a knee replacement, they are often hoping for a “miracle.” This is where responsible, evidence-based communication is paramount. I make it a point to set clear and realistic expectations.

I might explain the potential outcomes using ballpark figures based on current data: “Based on studies and my clinical experience, there might be a 50-60% chance of achieving significant pain reduction within four months.” I always follow this with a crucial disclaimer: “Nothing I do is 100% effective, and every patient’s response is unique.” This honest dialogue builds trust and frames the treatment not as a guaranteed cure, but as a powerful therapeutic trial aimed at shifting their physiology toward healing.

The Great Debate: Leukocyte-Rich vs. Leukocyte-Poor PRP

Another frequent topic of discussion is the type of PRP to use. The terms leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) are common, but their definitions can be ambiguous in the literature. Generally, a preparation is considered leukocyte-rich if the concentration of white blood cells (leukocytes) exceeds that in the patient’s baseline whole blood.

The current “buzz” in the field is moving beyond this simple dichotomy. We’re now exploring more sophisticated preparations, such as those that aim for monocytic enrichment while reducing neutrophils. Neutrophils are potent inflammatory cells, and the theory is that by minimizing their numbers while retaining monocytes (which can convert into tissue-healing macrophages), we can optimize the regenerative response. This involves very precise centrifugation to isolate the “buffy coat”—the layer between the red blood cells and the plasma—where these valuable cells reside.

However, there’s a trade-off. As we become more aggressive in isolating specific cell layers to reduce neutrophils, we risk losing some of the larger platelets and their associated growth factors, which are located deeper within the buffy coat. My clinical takeaway is this: for most osteoarthritic joints, especially large ones like the knee, the total dose of platelets and growth factors is arguably more important than the minute composition of leukocytes.

When to Prioritize Leukocyte-Poor Preparations

There are specific scenarios where I would deliberately choose a leukocyte-poor or even a platelet-poor plasma (PPP) preparation:

• Injections near nerves or the spine: The inflammatory response from LR-PRP could potentially irritate neural structures.
• Patients with extreme inflammatory sensitivity: For individuals who you know will have a very strong and painful post-injection flare, a less inflammatory preparation may be prudent.

Ultimately, for a standard knee OA injection, the vast majority of commercial systems will produce a preparation that is, by definition, leukocyte-rich. The post-injection inflammatory flare is typically transient (24-48 hours) and manageable. The potent anti-inflammatory and regenerative benefits of a high-dose, high-quality PRP preparation often outweigh concerns about a temporary increase in pain.

The Role of Peptides and Adjunctive Therapies

The conversation naturally turns to what else we can do to enhance outcomes. “What about combining PRP with peptides like BPC-157” is a question I hear more and more.

BPC-157 is a peptide chain that has gained attention for its potential healing properties, particularly through a process called angiogenesis—the formation of new blood vessels. Animal studies have suggested that BPC-157 can promote tissue repair. The theoretical synergy with PRP is compelling: PRP initiates a powerful healing and signaling cascade, and BPC-157 could potentially support this by improving blood supply to the targeted tissues, delivering more nutrients, and facilitating waste removal.

While robust human clinical trial data on this specific combination for OA are still forthcoming, the basic science is promising. In my practice, we might consider using therapies that promote angiogenesis in the weeks leading up to a PRP injection to “prepare the soil” for the “seeds” of the PRP.

The Impact of Cortisone and NSAIDs

It is critically important to understand how other common treatments can interfere with regenerative therapies. Cortisone injections, which are powerful anti-inflammatory steroids, can be detrimental to the healing process that PRP aims to stimulate. Corticosteroids can be toxic to chondrocytes (cartilage cells) and suppress the very cellular activity we want to encourage.

Therefore, we must observe a washout period. The residency time of a steroid in a joint is typically around 30-45 days. I recommend waiting a minimum of four to six weeks after a cortisone injection before proceeding with PRP. A similar principle applies to systemic or intramuscular steroid use and oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). While the washout period for oral medications is shorter, they should be stopped before and after the PRP procedure to allow the necessary initial inflammatory phase of healing to occur.

Optimizing the Dose: The “More is More” Philosophy

One of the most significant paradigm shifts in PRP therapy for OA, supported by researchers like Dr. Chad Prodromos, is the concept of platelet dosage. The emerging evidence strongly suggests that the total number of platelets injected into the joint is a critical determinant of success.

This has led to a clinical strategy of maximizing the volume and concentration of the injectate. If a patient’s knee joint can comfortably accommodate a larger volume, I will use it. For example, instead of a standard 3-4 mL injection, I might use 6, 8, or even more milliliters of PRP if the space allows.

The Syringe-Stacking Technique

To achieve this, my medical assistants process the blood and separate the resulting PRP into multiple labeled syringes. Syringe “1” contains the plasma-rich top layer, while the last syringe (e.g., syringe “4”) contains the most concentrated, platelet-dense portion from the bottom of the buffy coat.

If I’m treating a patient with severe OA and have ample joint space, I will inject the syringes in reverse order:

1. Inject the most concentrated PRP first (syringe “4”).
2. Follow with the next most concentrated (syringe “3”).
3. Continue “stacking” the layers into the joint.

This technique ensures we deliver the highest possible dose of platelets and growth factors directly to the target tissue. If a joint is particularly inflamed and prone to swelling (recurrent effusions), I might also utilize the platelet-poor plasma (PPP) from the top layer. PPP contains exosomes and other anti-inflammatory proteins that can help calm the joint environment.

The Foundational Role of Integrative Chiropractic Care

While these advanced cellular therapies are powerful, they do not exist in a vacuum. As a Doctor of Chiropractic, I view them as one component of a comprehensive, integrative treatment plan. The success of a PRP injection is profoundly influenced by the patient’s biomechanical health.

Chiropractic care is essential for several reasons:

• Restoring Proper Biomechanics: If a patient has misalignments in the spine, pelvis, hips, or feet, it creates abnormal loading patterns on the knee joint. No matter how successful a PRP injection is at healing cartilage, if the joint continues to be subjected to uneven stress, the degeneration will persist. Chiropractic adjustments correct these misalignments, ensuring that forces are distributed evenly across the joint, creating an optimal environment for the injected cells to work.
• Improving Neurological Function: Spinal adjustments can improve proprioception—the body’s sense of its position in space. Better proprioception leads to improved muscle coordination and stability around the knee, protecting it from further injury.
• Enhancing Mobility and Function: Chiropractic care, combined with targeted physical therapy, focuses on restoring a full and healthy range of motion. Movement is critical for joint health as it helps circulate synovial fluid, which nourishes the cartilage. After a PRP injection, a carefully prescribed movement and rehabilitation plan is crucial to guide the healing process and translate cellular repair into functional improvement.

In my clinic, we see the body as an interconnected system. Treating knee OA effectively means looking at the entire kinetic chain—from the ground up and the spine down. A PRP injection can repair the “part,” but integrative chiropractic care ensures the “whole” system is functioning correctly to support and sustain that repair. This is the essence of true functional medicine: addressing the root cause, not just the symptom.

---

References

1. Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. R., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 49(1), 249–260. https://doi.org/10.1177/0363546520909397
2. Prodromos, C., F-C, F., & C, C. (2022). Platelet Rich Plasma for the Treatment of Knee Osteoarthritis; A Review of the Literature and a New Method of Classifying and Using these Formulations. Journal of Cartilage & Joint Preservation, 2(4), 100057. https://doi.org/10.1016/j.jcjp.2022.100057
3. Seo, B., Lee, J., Kim, J., & Park, D. (2021). Effects of Body Mass Index on the Outcomes of Platelet-Rich Plasma Injection in Patients with Knee Osteoarthritis. Journal of Clinical Medicine, 10(22), 5278. https://doi.org/10.3390/jcm10225278
4. Chang, K.-V., Chen, L.-C., Hsieh, P.-C., Chiu, Y.-H., Wang, T.-G., & Wu, W.-T. (2021). Comparative Effectiveness of Platelet-Rich Plasma, Dextrose Prolotherapy, and Saline Injection for Chronic Rotator Cuff Disease: A Meta-Analysis of Randomized Controlled Trials. Archives of Physical Medicine and Rehabilitation, 102(4), 743-755.e3. https://doi.org/10.1016/j.apmr.2020.09.390